Oral Ranirestat in Diabetic Sensorimotor Polyneuropathy (Eisai 291)

• Research type

  Research Study

• Full title

  A 2-year, Randomized, Double-blind, Placebo-controlled, Multi-centre, Phase II-III Study to Evaluate the Efficacy and Safety of Oral Ranirestat (40 and 80 mg) in Mild to Moderate Diabetic Sensorimotor Polyneuropathy

• IRAS ID

  26692

• Contact name

  Solomon Tesfaye

• Eudract number

  2008-002843-18

• ISRCTN Number

  requested

• Research summary

  N/A

• REC name

  London - West London & GTAC Research Ethics Committee

• REC reference

  09/H0803/98

• Date of REC Opinion

  21 Sep 2009

• REC opinion

  Further Information Favourable Opinion